Article Details
Retrieved on: 2022-10-05 02:26:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vir Biotechnology Inc said on Tuesday it had received $55 million in funding from the U.S. government to support its influenza-focused antibody ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here